Drug/device combinations for local drug therapies and infection prophylaxis.
about
Antimicrobial technology in orthopedic and spinal implantsTitanium-Based Hip Stems with Drug Delivery Functionality through Additive ManufacturingNew strategies to improve results of mesh surgeries for vaginal prolapses repair--an updatePolypeptide multilayer film co-delivers oppositely-charged drug molecules in sustained mannersCalcium binding-mediated sustained release of minocycline from hydrophilic multilayer coatings targeting infection and inflammationTriggered drug release from superhydrophobic meshes using high-intensity focused ultrasound.Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus.Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffoldsDelivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures.Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes.Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.Self-protecting bactericidal titanium alloy surface formed by covalent bonding of daptomycin bisphosphonatesAntibiotic-containing polymers for localized, sustained drug deliverySurface-mediated release of a small-molecule modulator of bacterial biofilm formation: a non-bactericidal approach to inhibiting biofilm formation in Pseudomonas aeruginosa.Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug.Metal ion-assisted self-assembly of complexes for controlled and sustained release of minocycline for biomedical applications.Synthesis and characterization of a library of in-situ curing, nonswelling ethoxylated polyol thiol-ene hydrogels for tailorable macromolecule delivery.Dual functional polyelectrolyte multilayer coatings for implants: permanent microbicidal base with controlled release of therapeutic agents.Dual mode antibacterial activity of ion substituted calcium phosphate nanocarriers for bone infectionsSirolimus-eluting dextran and polyglutamic acid hybrid coatings on AZ31 for stent applications.Development of a Novel Model for the Assessment of Dead-Space Management in Soft TissueRNA therapeutics targeting osteoclast-mediated excessive bone resorption.Polyactives: controlled and sustained bioactive release via hydrolytic degradation.Role of plasma fibronectin in the foreign body response to biomaterialsNanoporous Superhydrophobic Coatings that Promote the Extended Release of Water-Labile Quorum Sensing Inhibitors and Enable Long-Term Modulation of Quorum Sensing in Staphylococcus aureus.Characterization of drug-release kinetics in trabecular bone from titania nanotube implants.Intraluminal Release of an Antifungal β-Peptide Enhances the Antifungal and Anti-Biofilm Activities of Multilayer-Coated Catheters in a Rat Model of Venous Catheter InfectionSurface-mediated release of a synthetic small-molecule modulator of bacterial quorum sensing: gradual release enhances activity.Highly porous drug-eluting structures: from wound dressings to stents and scaffolds for tissue regenerationMultilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeuticsNitric oxide-releasing xerogels synthesized from N-diazeniumdiolate-modified silane precursorsSilica-based mesoporous nanoparticles for controlled drug delivery.Facile synthesis, characterization, and antimicrobial activity of cellulose-chitosan-hydroxyapatite composite material: a potential material for bone tissue engineering.Hydrophobic Effects in the Critical Destabilization and Release Dynamics of Degradable Multilayer Films.Similarities and differences in coatings for magnesium-based stents and orthopaedic implants.A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response.Hybrid Nanostructures Containing Sulfadiazine Modified Chitosan as Antimicrobial Drug Carriers.Antibacterial surfaces for biomedical devices.Spatiotemporal effects of a controlled-release anti-inflammatory drug on the cellular dynamics of host response.Triggered drug delivery from biomaterials.
P2860
Q26747553-D77E1221-84AB-4200-A554-78DC55A8B1FEQ26778597-AF3FA2B8-870E-4E9E-829E-5B5C72D20A79Q26781585-0E748DC5-C4FA-43D7-BBB7-7A808E999714Q28385373-4C637721-B7F7-4B8B-98D5-442BDD224555Q28538368-011F944B-81D4-4D9C-A329-DC7786973906Q30431665-ADAD983E-51EB-430F-836F-0824C98C764CQ33716086-4109FF11-0E63-438B-B14F-F1518C62F314Q33742858-6DC8D42D-098B-4A54-BAA2-9C2D95BDBA15Q33800752-8581762F-2809-4485-8FD2-605C8DDE1DBCQ34145535-4883B0CB-5E10-4A5E-A00D-92E6C908C5C6Q34288026-40C6CDC0-0DA7-4BAA-9EE3-25550F642907Q34330727-73EA4FC4-036D-4B9F-829F-DD506FB24718Q34364393-C386A640-147B-4AD9-A914-06AE8B53E3F2Q34591793-45789E78-D711-4F7C-ABEB-A0452FCFEFC6Q34713899-E182610F-64C9-4F1E-AE24-D13CF8AC6879Q35041149-7293873D-AF22-4150-B621-D7E64F07E189Q35405498-ED084702-D088-4BC2-8A72-20B3BDA9A8CFQ35555578-8F68E348-2EDC-4301-A641-35E98F37A894Q35559811-D0982701-3631-4E39-911A-48FB8687E806Q35707420-9D3F8347-7C7A-441E-91A8-A6BEAB576A4DQ35754816-E1A4F6AA-2BD5-4FFF-9EA4-2BF0DAFAB001Q35800463-30BA4910-610F-4508-A7EA-0D1D3313C054Q35902758-72D3E664-DE8B-4F2F-A6C1-1CA4BF6BA20DQ35945230-9D1FFEDD-C743-42C1-BDA3-A27F49AD8227Q36158783-8CF05AAB-6F4C-43C9-B068-CBD3D3A049D9Q36247063-59401FA6-A218-4E65-BA2F-87273D24F2D9Q36458379-1E6438B3-63FA-4C2D-B13C-DD3E7A82DBE8Q36590719-4628B871-63A5-43C8-9E16-0CDF47F72CF5Q36597457-057A85A6-B34C-4781-9E06-A349D3C7A71BQ36779195-60266C0A-22AF-4C8F-8B73-A308013FC560Q36979307-B7C8DF78-BB75-4CA3-B755-B11824DA5A66Q37151406-63EF59DA-07D5-4265-A95F-482DCE359AE5Q37209866-97E13242-E462-4B9A-A753-76CDDC915480Q37234817-179B41AD-12CF-47FA-9042-F08A257B662EQ37300521-BB139CF2-D053-4434-AF82-C2770F846E54Q37404318-2D9F47F2-3907-4851-8BC7-5AD896544197Q37594408-7CF11867-B83F-4068-8CEC-13D1051A5C43Q37596429-12E2A957-77F5-4467-90B2-37A84CA5CB3CQ37613625-2C4B8BF0-19A2-445D-AC8B-155F34C9954BQ37703238-DF4E4A3F-F83D-456B-AEB5-9C6958D2CE3C
P2860
Drug/device combinations for local drug therapies and infection prophylaxis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Drug/device combinations for local drug therapies and infection prophylaxis.
@ast
Drug/device combinations for local drug therapies and infection prophylaxis.
@en
type
label
Drug/device combinations for local drug therapies and infection prophylaxis.
@ast
Drug/device combinations for local drug therapies and infection prophylaxis.
@en
prefLabel
Drug/device combinations for local drug therapies and infection prophylaxis.
@ast
Drug/device combinations for local drug therapies and infection prophylaxis.
@en
P1433
P1476
Drug/device combinations for local drug therapies and infection prophylaxis.
@en
P2093
David W Grainger
P304
P356
10.1016/J.BIOMATERIALS.2005.11.031
P577
2005-12-06T00:00:00Z